AMPD1 Is Associated With the Immune Response and Serves as a Prognostic Marker in HER2-Positive Breast Cancer

por Long Wang, Long Wang, Xue Zhang, Mengxue Wang, Mengxue Wang, Yunhai Li, Jiali Xu, Jiali Xu, Jiaying Wei, Hongzhong Li, Guosheng Ren, Guosheng Ren, Xuedong Yin
Publicado 2021

Efficacy and Safety of Adding Immune Checkpoint Inhibitors to Neoadjuvant Chemotherapy Against Triple-Negative Breast Cancer: A Meta-Analysis of Randomized Controlled Trials

por Yunhai Li, Lei Xing, Fan Li, Hong Liu, Lu Gan, Dejuan Yang, Mengxue Wang, Xuedong Yin, Hongyuan Li, Guosheng Ren, Guosheng Ren
Publicado 2021